Supreme Court to Weigh In on Mifepristone Access Amid Ongoing Legal Disputes
Two pharmaceutical companies are appealing to the U.S. Supreme Court to reinstate mail-order access to mifepristone, following a suspension by an appeals court.
Editorial Staff
1 min read
Updated 5 days ago
The legal battle over mifepristone, a medication used for abortion, continues as two drugmakers seek intervention from the U.S. Supreme Court. They are requesting the restoration of mail-order access to the pill.
This appeal comes in the wake of an appeals court decision that has temporarily halted deliveries of mifepristone, raising concerns about access to this medication.
In addition to the mifepristone controversy, the pharmaceutical industry is witnessing significant developments, including a notable deal involving UCB.